Delivery Order SPE2DB20D2104-SPE2DB23FQ71N
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.48 firm fixed-price contract is for the supply of JANUMET XR 50-1,000 MG tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 30, 2023 and was awarded on November 29, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of Janumet XR 50-1,000 mg, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $5,254.26 and a completion date of June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,247.79, is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 28, 2025 and is a firm fixed-price delivery order contract. No set-aside designation was used for this award....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET XR 50-1,000 MG TABLETS, a prescription medication used to treat type 2 diabetes. The contract has a ceiling value of $1,815.89 and runs through January 15, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,892.86, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to manage diabetes. The contract has an ultimate completion date of October 6, 2023 and is a firm fixed-price delivery order with no set-aside designation....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $1,823.41 and a completion date of May 4, 2023. No set-aside requirements were used for this award. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUMET XR 50-1,000 MG tablets, a medication used to manage diabetes. The contract has a ceiling value of $2,433.17 and runs through December 27, 2024. The contract is a firm-fixed-price delivery order, meaning the price is set and will not change. This appears to be a task order...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,002.02 contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a medication for diabetes management. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,936.63, is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of January 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999 that...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,166.95, is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FQ71NDelivery Order
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,726.26, is for the delivery of JANUMET XR 50-1,000 MG TABLET 60S, a prescription medication used for the treatment of type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of October 14, 2022. This Delivery Order contract is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/13/22 |